KIM, Y. Zanolimumab (Humax-CD4), a fully human monoclonal antibody with significant clinical responses in cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 3, n. 1, 2009. DOI: 10.4081/hmr.v3i1.540. Disponível em: https://www.pagepress.org/journals/hmr/article/view/540. Acesso em: 5 may. 2024.